Business Context and Reporting Period
This Form 8-K, filed on May 21, 2013, by Alkermes Plc., reports a material change in the company's fiscal year-end from March 31 to December 31. The filing also references a press release issued on May 23, 2013, which announced financial results for the fiscal year 2013 and provided financial expectations for the nine-month transition period ending December 31, 2013.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the referenced press release (Exhibit 99.1), which is not included in the provided text.
Material Changes
- Fiscal Year Change: The Audit and Risk Committee approved a change to the fiscal year-end from March 31 to December 31.
- Compensation Plan Amendment: The company amended its Affiliated Company Reporting Officer Performance Pay Plan to align with the new fiscal year. Performance awards for the period April 1, 2013, to December 31, 2013, will be prorated.
- Reporting Officers: The plan covers nine senior officers, including the CEO, President, CFO, and various Senior Vice Presidents.
Guidance, Outlook, and Risks
Management has set specific performance objectives for the nine-month transition period, which include executing on the clinical stage pipeline, achieving financial guidance, preparing commercial capabilities, and managing key business partners. The filing notes that the Committee reserves the right to modify the performance plan or objectives in response to changing business conditions. Specific financial guidance numbers are not detailed in this text.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for specific revenue, net loss, and cash position figures for fiscal year 2013.
- Verify the specific financial guidance targets for the nine months ending December 31, 2013, as referenced but not detailed in this report.
- Confirm the impact of the fiscal year change on the timing of future quarterly and annual reporting.
- Examine the amended performance pay plan (Exhibit 10.1) to understand the specific metrics tied to executive compensation for the transition period.